InsidersTradesSigma
申报总数
公司
▲ 买入（3 笔）
▼ 卖出（4 笔）
内部人交易记录
高级管理人员已披露买入
3
已披露卖出
4
T+90 胜率
100%
T+90 平均收益
+14.9%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Browse the complete record of transactions filed by Hayes Christopher G., Directeur Juridique. Director active across 1 company, notably Verrica Pharmaceuticals Inc.. In total, 11 filings have been logged. Split: 3 buys · 4 sells. Total volume traded: €323k. Activity tracked since 4 June 2021. The latest transaction was disclosed on 17 March 2025 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Hayes Christopher G.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报11 总计
4,315 股@ US$0.650.8% 占其流量Common StockSEC:0001415889-25-008505:0
150,000 股0Common StockSEC:0001415889-25-003232:0
26,183 股@ US$2.6618.2% 占其流量Common StockSEC:0001415889-24-022427:0
21,649 股@ US$7.0640.9% 占其流量Common StockSEC:0001415889-24-019970:0
40,000 股0Common StockSEC:0001415889-24-008543:0
22,141 股@ US$2.9317.7% 占其流量Common StockSEC:0001209191-23-055527:0
75,000 股0Common StockSEC:0001209191-23-047521:0
100,000 股0Common StockSEC:0001209191-23-043306:0
7,500 股@ US$3.407.4% 占其流量Common StockSEC:0001209191-22-041835:0
标准退出：2022年10月9日 (T+90)
5,714 股@ US$2.103.4% 占其流量Common StockSEC:0001209191-22-040616:0
标准退出：2022年10月3日 (T+90)
2,500 股@ US$9.796.2% 占其流量Common StockSEC:0001209191-21-038481:0
标准退出：2021年9月2日 (T+90)
11 条申报中的 11 条
About Hayes Christopher G.
Hayes Christopher G. is Directeur Juridique at Verrica Pharmaceuticals Inc. (CHIEF LEGAL OFFICER, XNAS). Across 11 filings in total, the 11 sampled recent filings span from 2021-06-07 to 2025-03-18, with EUR 57,250 in buys and EUR 265,931 in sells, and the most frequent transaction nature being sale.
